[1]
“Validation of LC-MS/MS Method for Monitoring of Upadacitinib in Rat Plasma Samples”, Journal of Pharmaceutical Negative Results, vol. 13, no. 2, pp. 102–107, Jun. 2022, Accessed: Jun. 10, 2026. [Online]. Available: https://pnrjournal.com/index.php/home/article/view/196